Back to trial details

Intake questionnaire

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Applying to University of Pennsylvania · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Solid Tumors?
3. Are you able to travel to Philadelphia for study visits?